To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval, making it the first precision medicine combo for patients with BRCA2-mutated metastatic ...

Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Sir Chris Hoy has revealed he is still reeling off the “worst crash I’ve ever had” as he continues his heart-wrenching battle with prostate cancer. The six-time Olympic cycling champion suffered the ...

JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (DRTS) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, today announced that the ...

University of Westminster provides funding as a member of The Conversation UK. A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have ...

Here’s a PSA about PSA—meaning a public service announcement about prostate specific antigen. Although checking the PSA levels in your blood is a routine way of screening for prostate cancer, just ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between scans or start aggressive treatment. Those with certain types of medium-risk ...